Assertio Holdings Inc (ASRT)
1.03
+0.02
(+1.98%)
USD |
NASDAQ |
May 03, 16:00
1.025
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Cash from Operations (TTM): 49.60M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 49.60M |
September 30, 2023 | 70.59M |
June 30, 2023 | 78.06M |
March 31, 2023 | 73.89M |
December 31, 2022 | 78.60M |
September 30, 2022 | 56.03M |
June 30, 2022 | 50.64M |
March 31, 2022 | 37.18M |
December 31, 2021 | 5.523M |
September 30, 2021 | -4.59M |
June 30, 2021 | -23.68M |
March 31, 2021 | -44.74M |
December 31, 2020 | -65.57M |
September 30, 2020 | -51.74M |
June 30, 2020 | -3.393M |
March 31, 2020 | 38.22M |
December 31, 2019 | 90.48M |
September 30, 2019 | 98.38M |
June 30, 2019 | 135.24M |
March 31, 2019 | 126.67M |
December 31, 2018 | 72.50M |
September 30, 2018 | 84.00M |
June 30, 2018 | 10.02M |
March 31, 2018 | 19.19M |
December 31, 2017 | 62.17M |
Date | Value |
---|---|
September 30, 2017 | 75.94M |
June 30, 2017 | 96.43M |
March 31, 2017 | 103.35M |
December 31, 2016 | 71.26M |
September 30, 2016 | 96.76M |
June 30, 2016 | 128.23M |
March 31, 2016 | 138.79M |
December 31, 2015 | 152.37M |
September 30, 2015 | 89.00M |
June 30, 2015 | 39.55M |
March 31, 2015 | 6.909M |
December 31, 2014 | -55.92M |
September 30, 2014 | -59.75M |
June 30, 2014 | -44.93M |
March 31, 2014 | -50.70M |
December 31, 2013 | 9.754M |
September 30, 2013 | 4.704M |
June 30, 2013 | -9.824M |
March 31, 2013 | -24.34M |
December 31, 2012 | -30.98M |
September 30, 2012 | -40.00M |
June 30, 2012 | -49.30M |
March 31, 2012 | -33.66M |
December 31, 2011 | 57.65M |
September 30, 2011 | 73.44M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-65.57M
Minimum
Dec 2020
135.24M
Maximum
Jun 2019
35.20M
Average
49.60M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
Ocular Therapeutix Inc | -70.23M |
Cormedix Inc | -38.41M |
Verastem Inc | -86.46M |
Puma Biotechnology Inc | 27.01M |
CytomX Therapeutics Inc | -56.04M |